Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2004
10/20/2004CN1171871C 1-alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators
10/20/2004CN1171582C Oral pharmaceutical extended release dosage form
10/19/2004US6806369 N-formyl-n-hydroxy-2-(5-isoquinolinoxy)ethylamine anti-bacterial compounds
10/19/2004US6806368 Liquid crystalline 3,4:9,10-perylenetetacarbocylic acid diimides
10/19/2004US6806288 Cyclooxygenase-2 mediated disorders; reduces inflammation; fewer side effects
10/19/2004US6806268 Method for treating glaucoma V
10/19/2004US6806265 For therapy and prophylaxis of hiv infection
10/19/2004US6805854 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route
10/17/2004CA2425819A1 Organic luminescent compounds and methods of making and using same
10/17/2004CA2425797A1 Organic light emitting devices
10/14/2004WO2004087938A1 Novel physiologically active substances pf1270a, b and c
10/14/2004WO2004087880A2 Compounds and their use to treat diabetes and related disorders
10/14/2004WO2004087718A1 Process for the production of imidazopyridin-8-ones
10/14/2004WO2004087714A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase
10/14/2004WO2004087704A1 Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
10/14/2004WO2004087703A1 Process for the preparation of n,n,6-trimethyl-2-(4-methylphenyl)-imidazo[1,2-a]pyridine-3-acetamide
10/14/2004WO2004087702A2 Method for the enantioselective preparation of sulphoxide derivatives
10/14/2004WO2004087701A1 Cyclic benzimidazoles
10/14/2004WO2004087653A2 4-ring imidazole derivatives as modulators of metabotropic glutamate receptor-5
10/14/2004WO2004087145A2 Antibacterial agents
10/14/2004WO2004087053A2 Dipeptidyl peptidase inhibitors
10/14/2004WO2004086861A2 Fungicidal properties of sampangine and its analogs to agriculturally important fungal plant pathogens
10/14/2004WO2004078116A3 P38 inhibitors and methods of use thereof
10/14/2004WO2004056824A3 Naphthyridine derivatives and their use as fungicides
10/14/2004WO2004056727A3 Process of making chalcone derivatives
10/14/2004WO2004052291A3 Pyridines for treating injured mammalian nerve tissue
10/14/2004WO2004043367A3 Fused heterocyclic compounds and use thereof
10/14/2004WO2004037176A3 Quinazolinones and derivatives thereof as factor xa inhibitors
10/14/2004WO2004024939A3 Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof
10/14/2004US20040204591 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group
10/14/2004US20040204584 Alzheimer's disease; Parkinson's disease; antidepressants
10/14/2004US20040204453 For therapy of irritable bowel syndrome, drug addiction or dependency, including alcohol addiction, depression, anxiety, schizophrenia, anxiety, schizophrenia and eating disorders
10/14/2004US20040204450 For therapy of atherosclerosis, coronary artery disease, coronary heart disease, coronary vascular disease, peripheral vascular disease, dyslipidemia, hyperbetalipoproteinemia, hypoalphalipoproteinemia, hypercholesterolemia, hypertriglyceridemia, familial-hypercholesterolemia
10/14/2004US20040204438 such as N-[4-(4-amino-1H-imidazol[4,5-c]quinolin-1-yl)butyl]-5-(dimethylamino)-naphthalenesulfonamide; for induction of biosynthesis of cytokines; immunomodulators; antineoplastic agents
10/14/2004US20040204437 Substituted arylamine derivatives and methods of use
10/14/2004US20040204436 Imidazonaphthyridines
10/14/2004US20040204431 For therapy cardiovascular disease
10/14/2004US20040204428 Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligandsof the adenosine a2a receptor and their use as medicaments
10/14/2004US20040204421 Certain 1,3-disubstituted isoquinoline derivatives
10/14/2004US20040204419 For therapy of cancer
10/14/2004US20040204418 For prophylaxis and therapy of asthma, chronic obstructive pulmonary disease, chronic bronchitis, atopic dermatitis, urticaria, allergic rhinitis, allergic conjunctivitis, vernal conjunctivitis, eosinophilia, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis, Crohn's disease
10/14/2004US20040204416 Pharmaceutical composition for the treatment of CNS and other disorders
10/14/2004US20040204409 Useful as antagonists of NMDA (N-methyl-D-aspartate) NR2B receptor; for therapy of pain, stroke, traumatic brain injury, Parkinson's disease, Alzheimer's disease, depression, anxiety, migraine
10/14/2004US20040204402 Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression
10/14/2004US20040204398 Acylated piperazine derivatives as melanocortin-4 receptor agonists
10/14/2004US20040204397 Calcitonin gene related peptide receptor antagonists
10/14/2004US20040204369 Novel amide derivatives
10/14/2004US20040204347 administering an effective amount of an inhibitor of the interaction of glutamate with the alpha -amino-3-hydroxy-5-methyl-4-isoxazole-propionate (AMPA) receptor complex to treat demyelinating disorders
10/14/2004US20040204257 System for and a method of manufacturing personal golf putters
10/14/2004US20040202930 New electrode materials derived from polyquinonic ionic compounds and their use in electrochemical generators
10/14/2004US20040202617 Delivery of opioids through an inhalation route
10/14/2004US20040200388 Perylene-derivative based crystallization modifiers
10/14/2004DE10315572A1 Substituierte Pyrazole Substituted pyrazoles
10/14/2004CA2520896A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase
10/14/2004CA2520863A1 4-ring imidazole derivatives as modulators of metabotropic glutamate receptor-5
10/14/2004CA2520581A1 Cyclic benzimidazoles
10/14/2004CA2520288A1 Process for the production of imidazopyridin-8-ones
10/14/2004CA2520157A1 Method for the enantioselective preparation of sulphoxide derivatives
10/14/2004CA2518465A1 Dipeptidyl peptidase inhibitors
10/13/2004EP1466625A1 Preventives/remedies for urinary disturbance
10/13/2004EP1466527A1 Fused heterocyclic sulfonylurea compound, herbicide containing the same, and method of controlling weed with the same
10/13/2004EP1466174A2 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
10/13/2004EP1465900A1 Rho-kinase inhibitors
10/13/2004EP1465893A1 Derivatives of 5-(pyridin-3-yl)-1-azabicyclo (3.2.1) octane, the preparation thereof and the application of same in therapeutics
10/13/2004EP1465892A1 Glycinamides as factor xa inhibitors
10/13/2004EP1465889A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
10/13/2004EP1465888A2 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
10/13/2004EP1465880A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
10/13/2004EP1465878A1 Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors
10/13/2004EP1465869A1 Modulators of lxr
10/13/2004EP1465854A2 Chalcone derivatives and their use to treat diseases
10/13/2004EP1465631A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use
10/13/2004EP1465629A1 5-ht3 receptor antagonists and methods of use
10/13/2004EP1465626A2 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
10/13/2004EP1397137A4 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/13/2004EP1322309A4 High affinity small molecule c5a receptor modulators
10/13/2004EP1169038A4 Cyclic protein tyrosine kinase inhibitors
10/13/2004EP1128831B1 Pharmaceutical moxifloxacin preparation
10/13/2004EP1097934B1 Lk6-a derivatives
10/13/2004EP1086086B1 Imidazolyl derivatives and their use as somatostatin receptor ligands
10/13/2004CN1537112A Pyrimidine compound
10/13/2004CN1537111A Urea substituted imidazoquinolines
10/13/2004CN1537105A Quinazolines as MMP-13 inhibitors
10/13/2004CN1537100A Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives
10/13/2004CN1535968A Tetrahydro pyridyl or pyridyl heterocycle derivative
10/13/2004CN1535967A Preparation of spirocyclic template compound
10/13/2004CN1535958A Alpha-substituted pyrimidine. thioalkyl and alkyl ether compound
10/13/2004CN1535682A Medicine for improved bladder excretion capacity
10/13/2004CN1170828C Process for preparing matrine water aque and powder agent CO2 super critical extraction technology
10/12/2004US6803467 Intermediates for the production of quinolone carboxylic acid derivatives
10/12/2004US6803457 Adenosine receptors; for reduction of tissue damage resulting from hypoxia/cardiovascular disorders in mammals/humans
10/12/2004US6803374 Compounds useful for treating hepatitis C virus
10/12/2004US6803372 Such as cis-n-(4-benzoylphenyl)-4-hydroxy-3'-oxospiro (cyclohexane-1,1' (3'h)-isobenzofuran)-4-carboxamide for use as neuropeptide y receptor antagonist for treatment bulimia, obesity or diabetes
10/12/2004US6803366 Agent for improving learning or memory
10/12/2004US6803031 Aerosol comprises particles comprising at least 10 percent by weight of an erectile dysfunction drug, such as sildenafil, tadalafil or vardenafil.
10/07/2004WO2004085437A1 Non-nucleoside reverse transcriptase inhibitors
10/07/2004WO2004085436A2 Pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
10/07/2004WO2004085425A1 Fused azoles such as 2,5-disubstituted benzimidazoles, benzoxazoles and benzothiazoles as kinase inhibitors
10/07/2004WO2004085418A2 Xanthones, thioxanthones and acridinones as dna-pk inhibitors
10/07/2004WO2004085401A1 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity
1 ... 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 ... 646